143 related articles for article (PubMed ID: 20943766)
21. Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation.
Park JH; Jang HR; Kim DH; Kwon GY; Lee JE; Huh W; Choi SJ; Oh W; Oh HY; Kim YG
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F984-F996. PubMed ID: 28356286
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury.
Herrera MB; Bussolati B; Bruno S; Fonsato V; Romanazzi GM; Camussi G
Int J Mol Med; 2004 Dec; 14(6):1035-41. PubMed ID: 15547670
[TBL] [Abstract][Full Text] [Related]
23. Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.
Burks SR; Nguyen BA; Tebebi PA; Kim SJ; Bresler MN; Ziadloo A; Street JM; Yuen PS; Star RA; Frank JA
Stem Cells; 2015 Apr; 33(4):1241-53. PubMed ID: 25640064
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
Ghosh S; Maity P
Int Immunopharmacol; 2006 Oct; 6(10):1550-9. PubMed ID: 16919827
[TBL] [Abstract][Full Text] [Related]
25. The interactions between brain microvascular endothelial cells and mesenchymal stem cells under hypoxic conditions.
Liu K; Chi L; Guo L; Liu X; Luo C; Zhang S; He G
Microvasc Res; 2008 Jan; 75(1):59-67. PubMed ID: 17662311
[TBL] [Abstract][Full Text] [Related]
26. High passage number of stem cells adversely affects stem cell activation and myocardial protection.
Crisostomo PR; Wang M; Wairiuko GM; Morrell ED; Terrell AM; Seshadri P; Nam UH; Meldrum DR
Shock; 2006 Dec; 26(6):575-80. PubMed ID: 17117132
[TBL] [Abstract][Full Text] [Related]
27. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor.
Faleo G; Neto JS; Kohmoto J; Tomiyama K; Shimizu H; Takahashi T; Wang Y; Sugimoto R; Choi AM; Stolz DB; Carrieri G; McCurry KR; Murase N; Nakao A
Transplantation; 2008 Jun; 85(12):1833-40. PubMed ID: 18580478
[TBL] [Abstract][Full Text] [Related]
28. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.
Li W; Ma N; Ong LL; Nesselmann C; Klopsch C; Ladilov Y; Furlani D; Piechaczek C; Moebius JM; Lützow K; Lendlein A; Stamm C; Li RK; Steinhoff G
Stem Cells; 2007 Aug; 25(8):2118-27. PubMed ID: 17478584
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage.
Fu X; He Y; Xie C; Liu W
Cytotherapy; 2008; 10(4):353-63. PubMed ID: 18574768
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms.
Weil BR; Markel TA; Herrmann JL; Abarbanell AM; Meldrum DR
Surgery; 2009 Aug; 146(2):190-7. PubMed ID: 19628073
[TBL] [Abstract][Full Text] [Related]
32. Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action.
Yu J; Zheng C; Ren X; Li J; Liu M; Zhang L; Liang L; Du W; Han ZC
Scand J Immunol; 2010 Sep; 72(3):242-9. PubMed ID: 20696022
[TBL] [Abstract][Full Text] [Related]
33. Differentiation potential of human embryonic mesenchymal stem cells for skin-related tissue.
Wu M; Yang L; Liu S; Li H; Hui N; Wang F; Liu H
Br J Dermatol; 2006 Aug; 155(2):282-91. PubMed ID: 16882164
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis.
Sémont A; Mouiseddine M; François A; Demarquay C; Mathieu N; Chapel A; Saché A; Thierry D; Laloi P; Gourmelon P
Cell Death Differ; 2010 Jun; 17(6):952-61. PubMed ID: 20019749
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cells in renal function recovery after acute kidney injury: use of a differentiating agent in a rat model.
La Manna G; Bianchi F; Cappuccilli M; Cenacchi G; Tarantino L; Pasquinelli G; Valente S; Della Bella E; Cantoni S; Claudia C; Neri F; Tsivian M; Nardo B; Ventura C; Stefoni S
Cell Transplant; 2011; 20(8):1193-208. PubMed ID: 21092414
[TBL] [Abstract][Full Text] [Related]
36. Transcatheter injection-induced changes in human bone marrow-derived mesenchymal stem cells.
Heng BC; Hsu SH; Cowan CM; Liu A; Tai J; Chan Y; Sherman W; Basu S
Cell Transplant; 2009; 18(10):1111-21. PubMed ID: 19650972
[TBL] [Abstract][Full Text] [Related]
37. Enhanced renoprotective effect of HIF-1α modified human adipose-derived stem cells on cisplatin-induced acute kidney injury in vivo.
Wang WW; Li ZZ; Wang W; Jiang Y; Cheng J; Lu S; Zhang JY
Sci Rep; 2015 Jun; 5():10851. PubMed ID: 26044673
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia.
Kucic T; Copland IB; Cuerquis J; Coutu DL; Chalifour LE; Gagnon RF; Galipeau J
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F488-96. PubMed ID: 18524862
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
40. The use of stem cells in kidney disease.
Chhabra P; Brayman KL
Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
